Stay updated on SL-401 Combo With Pomalid/Dex in MM Clinical Trial
Sign up to get notified when there's something new on the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page.

Latest updates to the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s references and revision metadata were updated: a new American Cancer Society citation was added and the page revision was updated to v3.5.4, while several related topics and an older revision reference were removed.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA website release revision identifier was updated from **v3.5.2** to **v3.5.3**, reflecting a platform/version change rather than any change to the ClinicalTrials.gov study information.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded 'Multiple myeloma' as a condition/topic and a related topic link to MedlinePlus Genetics. Updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check46 days agoChange DetectedRemoved 'Multiple myeloma' and its related topic 'MedlinePlus Genetics' from the related topics section.SummaryDifference0.2%

- Check60 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to provide additional context and resources.SummaryDifference0.2%

- Check67 days agoChange DetectedRevision note added: v3.5.0. Related topics (Multiple myeloma and MedlinePlus Genetics) were removed, along with the prior revision note (v3.4.3).SummaryDifference0.2%

Stay in the know with updates to SL-401 Combo With Pomalid/Dex in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page.